Capital Insight Partners LLC Has $3.23 Million Position in Chemed Corporation $CHE

Capital Insight Partners LLC cut its position in Chemed Corporation (NYSE:CHE) by 21.9% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 7,220 shares of the company’s stock after selling 2,027 shares during the period. Capital Insight Partners LLC’s holdings in Chemed were worth $3,233,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. SVB Wealth LLC bought a new stake in Chemed during the 1st quarter worth approximately $30,000. WPG Advisers LLC bought a new stake in shares of Chemed during the first quarter worth $32,000. Creekmur Asset Management LLC acquired a new stake in shares of Chemed in the second quarter valued at $28,000. Parkside Financial Bank & Trust raised its holdings in shares of Chemed by 86.3% in the second quarter. Parkside Financial Bank & Trust now owns 95 shares of the company’s stock valued at $46,000 after buying an additional 44 shares during the last quarter. Finally, Geneos Wealth Management Inc. lifted its position in Chemed by 330.4% during the 1st quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after buying an additional 76 shares in the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Analyst Ratings Changes

CHE has been the subject of several research reports. Bank of America lowered their price objective on shares of Chemed from $610.00 to $595.00 and set a “buy” rating for the company in a research report on Wednesday, September 10th. Jefferies Financial Group upgraded shares of Chemed from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $490.00 to $550.00 in a research report on Tuesday, September 2nd. Weiss Ratings reiterated a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, October 8th. Royal Bank Of Canada dropped their target price on Chemed from $589.00 to $572.00 and set an “outperform” rating for the company in a research report on Monday, November 10th. Finally, Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 30th. Four analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, Chemed has an average rating of “Moderate Buy” and a consensus target price of $574.25.

Insiders Place Their Bets

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction on Monday, November 24th. The shares were sold at an average price of $437.55, for a total value of $875,100.00. Following the completion of the transaction, the chief executive officer owned 94,197 shares of the company’s stock, valued at $41,215,897.35. The trade was a 2.08% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 3.29% of the company’s stock.

Chemed Stock Performance

Shares of CHE stock opened at $435.26 on Monday. The firm’s 50 day moving average price is $435.57 and its two-hundred day moving average price is $458.29. Chemed Corporation has a 52-week low of $408.42 and a 52-week high of $623.60. The stock has a market cap of $6.16 billion, a PE ratio of 23.02, a PEG ratio of 2.43 and a beta of 0.46.

Chemed (NYSE:CHE) last released its quarterly earnings data on Tuesday, October 28th. The company reported $5.27 EPS for the quarter, missing analysts’ consensus estimates of $5.39 by ($0.12). Chemed had a net margin of 11.02% and a return on equity of 25.89%. The company had revenue of $624.90 million during the quarter, compared to the consensus estimate of $626.04 million. During the same quarter in the prior year, the company posted $5.64 EPS. The company’s revenue for the quarter was up 3.1% compared to the same quarter last year. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. As a group, sell-side analysts predict that Chemed Corporation will post 21.43 earnings per share for the current fiscal year.

Chemed Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, December 5th. Shareholders of record on Monday, November 17th were paid a $0.60 dividend. This represents a $2.40 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend was Monday, November 17th. Chemed’s dividend payout ratio is presently 12.69%.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.